Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1982 Nov;45:35–40. doi: 10.1289/ehp.824535

Phthalate esters as peroxisome proliferator carcinogens.

J R Warren, N D Lalwani, J K Reddy
PMCID: PMC1569007  PMID: 6754363

Abstract

The phthalate ester di(2-ethylhexyl) phthalate is both a peroxisome proliferator and a hepatic carcinogen. Peroxisome proliferators as a class are hepatocarcinogenic in rodent species. However, none of the peroxisome proliferators tested to date including the phthalate esters and related alcohol and acid analogs have demonstrated mutagenic or DNA-damaging activity in the in vitro Salmonella typhimurium/microsomal or the lymphocyte 3H-thymidine assays. A working hypothesis is proposed that peroxisome proliferation itself initiates neoplastic transformation of hepatic parenchymal cells by increasing intracellular rates of DNA-damaging reactive oxygen production. Evidence which supports such a hypothesis includes increased fatty acid beta-oxidation, elevated H2O2 levels, accumulation of peroxidized lipofuscin, disproportionately small increase in catalase, and elevated peroxisomal uricase activity which accompany peroxisome proliferation in hepatocytes. Direct testing of this hypothesis will provide insight into mechanisms of phthalate ester carcinogenicity and cytotoxicity.

Full text

PDF
36

Images in this article

36FIGURE 1.
on p.36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6858–6862. doi: 10.1073/pnas.78.11.6858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cadet J., Treoule R. Comparative study of oxidation of nucleic acid components by hydroxyl radicals, singlet oxygen and superoxide anion radicals. Photochem Photobiol. 1978 Oct-Nov;28(4-5):661–667. doi: 10.1111/j.1751-1097.1978.tb06991.x. [DOI] [PubMed] [Google Scholar]
  3. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979 Jul;59(3):527–605. doi: 10.1152/physrev.1979.59.3.527. [DOI] [PubMed] [Google Scholar]
  4. Farber E. Chemical carcinogenesis. N Engl J Med. 1981 Dec 3;305(23):1379–1389. doi: 10.1056/NEJM198112033052304. [DOI] [PubMed] [Google Scholar]
  5. Fitzgerald J. E., Sanyer J. L., Schardein J. L., Lake R. S., McGuire E. J., de la Iglesia F. A. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil. J Natl Cancer Inst. 1981 Nov;67(5):1105–1116. [PubMed] [Google Scholar]
  6. Gibson T. P., Briggs W. A., Boone B. J. Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis. J Lab Clin Med. 1976 Mar;87(3):519–524. [PubMed] [Google Scholar]
  7. Hanefeld M., Kemmer C., Leonhardt W., Kunze K. D., Jaross W., Haller H. Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liver. Atherosclerosis. 1980 Jun;36(2):159–172. doi: 10.1016/0021-9150(80)90225-7. [DOI] [PubMed] [Google Scholar]
  8. Inestrosa N. C., Bronfman M., Leighton F. Detection of peroxisomal fatty acyl-coenzyme A oxidase activity. Biochem J. 1979 Sep 15;182(3):779–788. doi: 10.1042/bj1820779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lalwani N. D., Reddy M. K., Mangkornkanok-Mark M., Reddy J. K. Induction, immunochemical identity and immunofluorescence localization of an 80 000-molecular-weight peroxisome-proliferation-associated polypeptide (polypeptide PPA-80) and peroxisomal enoyl-CoA hydratase of mouse liver and renal cortex. Biochem J. 1981 Jul 15;198(1):177–186. doi: 10.1042/bj1980177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lalwani N. D., Reddy M. K., Qureshi S. A., Reddy J. K. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis. 1981;2(7):645–650. doi: 10.1093/carcin/2.7.645. [DOI] [PubMed] [Google Scholar]
  11. Lazarow P. B., De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2043–2046. doi: 10.1073/pnas.73.6.2043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lazarow P. B. Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J Biol Chem. 1978 Mar 10;253(5):1522–1528. [PubMed] [Google Scholar]
  13. Lazarow P. B. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. Science. 1977 Aug 5;197(4303):580–581. doi: 10.1126/science.195342. [DOI] [PubMed] [Google Scholar]
  14. Massie H. R., Samis H. V., Baird M. B. The kinetics of degradation of DNA and RNA by H 2 O 2 . Biochim Biophys Acta. 1972 Jul 31;272(4):539–548. doi: 10.1016/0005-2787(72)90509-6. [DOI] [PubMed] [Google Scholar]
  15. Moody D. E., Reddy J. K. Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxicol Appl Pharmacol. 1978 Aug;45(2):497–504. doi: 10.1016/0041-008x(78)90111-4. [DOI] [PubMed] [Google Scholar]
  16. Moody D. E., Reddy J. K. Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42-348. J Cell Biol. 1976 Dec;71(3):768–780. doi: 10.1083/jcb.71.3.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moody D. E., Reddy J. K. Serum triglyceride and cholesterol contents in male rats receiving diets containing plasticizers and analogues of the ester 2-ethylhexanol. Toxicol Lett. 1982 Mar;10(4):379–383. doi: 10.1016/0378-4274(82)90233-8. [DOI] [PubMed] [Google Scholar]
  18. Osumi T., Hashimoto T. Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di-(i-ethylhexyl)phthalate. J Biochem. 1978 May;83(5):1361–1365. doi: 10.1093/oxfordjournals.jbchem.a132044. [DOI] [PubMed] [Google Scholar]
  19. Parshad R., Taylor W. G., Sanford K. K., Camalier R. F., Gantt R., Tarone R. E. Fluorescent light-induced chromosome damage in human IMR-90 fibroblasts. Role of hydrogen peroxide and related free radicals. Mutat Res. 1980 Nov;73(1):115–124. doi: 10.1016/0027-5107(80)90140-2. [DOI] [PubMed] [Google Scholar]
  20. Pollard E. C., Weller P. K. Chain scission of ribonucleic acid and deoxyribonucleic acid by ionizing radiation and hydrogen peroxide in vitro and in Escherichia coli cells. Radiat Res. 1967 Nov;32(3):417–440. [PubMed] [Google Scholar]
  21. Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature. 1980 Jan 24;283(5745):397–398. doi: 10.1038/283397a0. [DOI] [PubMed] [Google Scholar]
  22. Reddy J. K., Lalwani N. D., Reddy M. K., Qureshi S. A. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res. 1982 Jan;42(1):259–266. [PubMed] [Google Scholar]
  23. Reddy J. K., Moody D. E., Azarnoff D. L., Rao M. S. Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. Life Sci. 1976 May 1;18(9):941–945. doi: 10.1016/0024-3205(76)90412-4. [DOI] [PubMed] [Google Scholar]
  24. Reddy J. K., Rao M. S., Azarnoff D. L., Sell S. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. Cancer Res. 1979 Jan;39(1):152–161. [PubMed] [Google Scholar]
  25. Reddy J. K., Rao M. S. Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat. Br J Cancer. 1978 Oct;38(4):537–543. doi: 10.1038/bjc.1978.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reddy J. K., Rao S., Moody D. E. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976 Apr;36(4):1211–1217. [PubMed] [Google Scholar]
  27. Reddy M. K., Lalwani N. D., Qureshi S. A., Reddy J. K. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs. Hum Toxicol. 1982 Mar;1(2):135–147. doi: 10.1177/096032718200100205. [DOI] [PubMed] [Google Scholar]
  28. Stich H. F., Wei L., Lam P. The need for a mammalian test system for mutagens: action of some reducing agents. Cancer Lett. 1978 Oct;5(4):199–204. doi: 10.1016/s0304-3835(78)80039-1. [DOI] [PubMed] [Google Scholar]
  29. Svoboda D. J., Azarnoff D. L. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol. 1966 Aug;30(2):442–450. doi: 10.1083/jcb.30.2.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Svoboda D. J., Azarnoff D. L. Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 1979 Sep;39(9):3419–3428. [PubMed] [Google Scholar]
  31. Wang R. J., Ananthaswamy H. N., Nixon B. T., Hartman P. S., Eisenstark A. Induction of single-strand DNA breaks in human cells by H2O2 formed in near-uv (black light) irradiated medium. Radiat Res. 1980 May;82(2):269–276. [PubMed] [Google Scholar]
  32. Warren J. R. Damage of proliferating lymphoid cell deoxyribonucleic acid by methyl methanesulfonate and N-acetoxy-2-acetylaminofluorene. Cancer Lett. 1978 Nov;5(5):253–260. doi: 10.1016/s0304-3835(78)80022-6. [DOI] [PubMed] [Google Scholar]
  33. Warren J. R., Simmon V. F., Reddy J. K. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Cancer Res. 1980 Jan;40(1):36–41. [PubMed] [Google Scholar]
  34. Warren J. R., Summerville J. W. Activity of carcinogens, carcinogen analogs, and metabolic inhibitors in the lymphocyte tritiated thymidine assay. J Natl Cancer Inst. 1980 Dec;65(6):1321–1328. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES